|

Prediction Of Lymphedema In Patients With Inflammatory BreastCancer Using Preoperative Bioimpedance Measurements

RECRUITINGSponsored by M.D. Anderson Cancer Center
Actively Recruiting
SponsorM.D. Anderson Cancer Center
Started2026-09-16
Est. completion2027-12-31
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Eligibility Criteria All women≥18 years old with newly diagnosed inflammatory breast cancer without prior breast/axillary surgery who are eligible for standard of care (NST, MRM, and radiation therapy).

Exclusion Criteria Prior breast/axillary surgery. Participants with pacemakers or other implanted electronic medical devices. Participants with implanted metallic material. All vulnerable populations, including children, pregnant women, and cognitively impaired adult

Conditions6

Bioimpedance MeasurementBreast CancerCancerInflammatory Breast Cancer (IBC)LymphedemaPreoperative

Interventions1

Locations1 site

UT MD Anderson Cancer Center
Houston, Texas, 77030
Anthony Lucci, MD713-563-1871ALucci@mdanderson.org

Find trials near these locations

Related trials

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.